"Lba19a Multi-Institutional Randomized Phase 2 Trial of the Oncolytic Virus Reolysin in the First Line Treatment Metastatic Adenocarcinoma of the Pancreas (Map)" by T. Bekaii-Saab

Article

Lba19a Multi-Institutional Randomized Phase 2 Trial of the Oncolytic Virus Reolysin in the First Line Treatment Metastatic Adenocarcinoma of the Pancreas (Map)

Annals of Oncology / 39th European Society for Medical Oncology. ESMO Congress (2014)

T. Bekaii-Saab, Ohio State University
A.M. Noonan, Ohio State University
G. Lesinski, Ohio State University
S. Mikhail, Ohio State University
K. Ciombor, Ohio State University
S. Pant, University of Oklahoma
S. Aparo, Albert Einstein College of Medicine
S. Tahiri, Ohio State University
A. Thompson, Ohio State University
J. Sexton, Ohio State University
J.L. Marshall, Georgetown University
T. Mace, Ohio State University
C. Wu, Ohio State University
B. El-Rayes, Emory University
C. Timmers, Ohio State University
S. Geyer, Ohio State University
J. Zwiebel, National Institutes of Health
M.A. Villalona-Calero, Ohio State University

Link

Disciplines

Publication Date

September, 2014

DOI

10.1093/annonc/mdu438.19

Citation Information

T. Bekaii-Saab, A.M. Noonan, G. Lesinski, S. Mikhail, et al.. "Lba19a Multi-Institutional Randomized Phase 2 Trial of the Oncolytic Virus Reolysin in the First Line Treatment Metastatic Adenocarcinoma of the Pancreas (Map)" Annals of Oncology / 39th European Society for Medical Oncology. ESMO Congress Vol. 25 Iss. v1-iv (2014) p. 582
Available at: http://works.bepress.com/santiago-aparo/15/